This week on Contemporary OB/GYN®: Oct. 18 to Oct. 22


Here's what to look for this week on Contemporary OB/GYN®.

This week's topics include:

Diagnosing and treating vaginal discharge

Inappropriate treatment is widespread among women with vaginitis symptoms, according to a study conducted in a community practice setting.

Moderna, Johnson and Johnson COVID-19 boosters recommended by FDA

The advisory panel is also scheduled to discuss Merck antiviral pill late next month.

Changes in menstrual cycle length could signal increased risk of atherosclerosis

Using data from SWAN DHS, investigators determined changes in menstrual cycle length prior to a woman's final menstrual period were associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.

Combined contraceptive pills may reduce risk of diabetes in PCOS

A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.